BioVie Inc

BioVie Inc (BIVI) Financials

$2.160

-0.030 (-1.37%)At close

BIVI Profitability and Margins

Evaluating the bottom line, BioVie Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -151.06%, provide a clear picture of how effectively BIVI converts its operational activities into shareholder value.

BIVI Comparative Benchmarking

In the context of the broader market, BIVI competes directly with industry leaders such as AKTX and BCDA. With a market capitalization of $18.25M, it holds a significant position in the sector. When comparing efficiency, BIVI's gross margin of N/A stands against AKTX's N/A and BCDA's N/A. Such benchmarking helps identify whether BioVie Inc is trading at a premium or discount relative to its financial performance.

BioVie Inc Financial Performance

BioVie has shown significant volatility in its financials, with a current ratio of 3.59 indicating good short-term liquidity, but it has consistently reported negative net income, with the latest quarter showing a loss of -5,645,532 USD.

Financials

FY2026Q4
YoY:
+77.17%
-6.11M
Operating Profit
FY2026Q4
YoY:
+61.80%
-5.65M
Net Income after Tax
FY2026Q4
YoY:
-62.23%
-0.71
EPS - Diluted
FY2025Q3
-1.25M
Free Cash Flow

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started